Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Loading
Home›
Research›
Investment Firms›
Viva BioInnovator
AddedFeb 15, 2024
UpdatedJun 28, 2026
Viva BioInnovator

Viva BioInnovator

Operating

Viva BioInnovator: A leading biotech incubator, nurturing startups from idea to clinical program with unique investment models.

Location
Shanghai, Shanghai, CN
Founded
2008
Firm
Compare
Portfolio
Employees
Website

Viva BioInnovator (VBI) is the specialized investment and incubation arm of Viva Biotech Holdings, focusing on biotech startups across all indications and drug types. They nurture and accelerate startup growth from idea to clinical program, primarily investing in seed and Series A rounds, with occasional participation in Series B funding.

VBI's portfolio includes notable companies such as Amberstone Biosciences, ArrePath, and Arthrosi Therapeutics. Their unique investment and incubation model, developed since 2014, leverages Viva Biotech's expertise in drug discovery services. VBI offers world-leading proprietary technologies and resources to support early-stage biotech companies, providing a comprehensive platform for startup development and growth.

Viva BioInnovator - Portfolio Snapshot

Portfolio activity breakdown across disclosed investments and stages

Total Investments15
Current Portfolio Count14
Total Portfolio Exits0

Top Investment Stages

Seed7 (46.7%)
Series A6 (40.0%)
Series B2 (13.3%)

Stage Mix

Seed 47%Series A 40%Series B 13%

Concentration shown as share of disclosed investments by stage.

Recent Investments

Deka Biosciences logo

Deka Biosciences

ArrePath logo

ArrePath

Amberstone Biosciences logo

Amberstone Biosciences

Fuse Biotherapeutics logo

Fuse Biotherapeutics

IpiNovyx Bio logo

IpiNovyx Bio

Karma Biotechnologies logo

Karma Biotechnologies

Iterion Therapeutics logo

Iterion Therapeutics

Basking Biosciences logo

Basking Biosciences

Forkhead BioTherapeutics logo

Forkhead BioTherapeutics

QurAlis logo

QurAlis

Riparian Pharmaceuticals logo

Riparian Pharmaceuticals

Dogma Therapeutics logo

Dogma Therapeutics

Arthrosi Therapeutics logo

Arthrosi Therapeutics

Tabomedex logo

Tabomedex

Viva BioInnovator - Similar Investment Firms

Emerald Bioventures logo

Emerald Bioventures

BioVenture logo

BioVenture

bioventure.com.cn

IndieBio logo

IndieBio

indiebio.co

Vive Collective logo

Vive Collective

vivecollective.com

Vesper Ventures logo

Vesper Ventures

vesper-bio.com

EVX Ventures logo

EVX Ventures

evx.ventures

Novalis Biotech logo

Novalis Biotech

noval.is

ClavystBio logo

ClavystBio

clavystbio.com

BioInnovation logo

BioInnovation

V-Bio Ventures logo

V-Bio Ventures

v-bio.ventures

Woodside Incubator logo

Woodside Incubator

ProVeg Incubator logo

ProVeg Incubator

Mission BioCapital logo

Mission BioCapital

SciFounders logo

SciFounders

scifounders.com

Investidores.VC logo

Investidores.VC

investidores.vc

Viva BioInnovator - Classification

Also Known As
  • Viva Biotech Ltd
NAICS
  • 520000Finance and Insurance
  • 523000Securities, Commodity Contracts, and Other Financial Investments and Related Activities
  • 523900Other Financial Investment Activities
  • 523990All Other Financial Investment Activities
  • 523999Miscellaneous Financial Investment Activities
SIC
  • 7300Business Services
Show 2 more industry codes
NAICS
  • 540000Professional, Scientific, and Technical Services
  • 541000Professional, Scientific, and Technical Services